Quintrio
Home

PHARMACEUTICAL PREPARATIONS

NanoViricides Inc.

NNVC

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company is engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific antiviral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing. The Company's platform is based on host-mimicry and thereby has uniquely enabled the development of broad-spectrum antiviral drugs that the viruses would be unable to escape, a critical unmet need in antiviral therapeutics.

Last trade $1.17
Day change -$0.07 (-5.65%)
Day range $1.16 – $1.30
Volume 209,708
Market cap $32M

Open XASE

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

Valuation

Market capitalization
$31.67M
Price / earnings
—
Price / book
3.65×
Price / sales
—
EV / sales
—
EV / EBITDA
-3.71×

Profitability

Earnings per share
-$0.32
Return on assets
-83.24%
Return on equity
-94.65%
Dividend yield
0%

Liquidity and leverage

Debt / equity
0×
Current ratio
2.66×
Quick ratio
2.66×
Cash ratio
2.35×

Cash flow

Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$7.78M

Ratios use trailing-twelve-month financials and market data as of Nov 16, 2026.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

Income statement for NNVC, quarterly periods
Line itemQ4 FY2026 Jun 30, 2026Q3 FY2026 Mar 31, 2026Q2 FY2026 Dec 31, 2025Q1 FY2026 Sep 30, 2025Q4 FY2025 Jun 30, 2025Q3 FY2025 Mar 31, 2025Q2 FY2025 Dec 31, 2024Q1 FY2025 Sep 30, 2024
Revenue$0$0$0$0$0$0$0$0
Cost of revenue$0$0$0$0$0$0$0$0
Gross profit$0$0$0$0$0$0$0$0
Selling, general and administrative$936.32K$744.28K$1.11M$803.62K$938.2K$966.91K$902.7K$1.23M
Research and development$1.31M$1.29M$1.12M$993.07K$1.18M$1.28M$1.16M$1.93M
Total operating expenses$2.25M$2.03M$2.23M$1.8M$2.12M$2.25M$2.06M$3.17M
Operating income-$2.25M-$2.03M-$2.23M-$1.8M-$2.12M-$2.25M-$2.06M-$3.17M
Interest expense$0$0$0$0$0$0-$149$0
Income before taxes-$2.22M-$1.99M-$2.22M-$1.79M-$2.1M-$2.22M-$2.03M-$3.13M
Income taxes$0$0$0$0$0$0$0$0
Net income-$2.22M-$1.99M-$2.22M-$1.79M-$2.1M-$2.22M-$2.03M-$3.13M
Net income attributable to common shareholders-$2.22M-$1.99M-$2.22M-$1.79M-$2.1M-$2.22M-$2.03M-$3.13M
EBITDA-$2.12M-$1.9M-$2.1M-$1.66M-$1.95M-$2.06M-$1.86M-$2.97M
Basic earnings per share-$0.10-$0.09-$0.11-$0.10-$0.13-$0.14-$0.14-$0.23
Diluted earnings per share-$0.10-$0.09-$0.11-$0.10-$0.13-$0.14-$0.14-$0.23

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Investing.com

2 Small-Cap Biotechs That Could Reward Patient Investors

The article discusses two small-cap biotech companies with high-risk, high-potential investment opportunities: Mainz Biomed and NanoViricides. Both companies are developing innovative medical technologies but face significant financial challenges and are pre-revenue.

Benzinga

Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket

Gainers CytoMed Therapeutics Limited (NASDAQ: GDTC) shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday. Better Therapeutics, Inc. (NASDAQ: BTTX) shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes. Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday. Trinity Place Holdings Inc. (NYSE: TPHS) gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday. TC Biopharm (Holdings) Plc (NASDAQ: TCBP) shares rose 20.8% to $0.54 in pre-market trading. NanoViricides, Inc. (NYSE: NNVC) rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus. Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it ...

GlobeNewswire Inc.

NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City

SHELTON, Conn., May 04, 2023 (GLOBE NEWSWIRE) -- (via IBN) -- NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), a clinical stage global leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, announces that Anil R. Diwan, Ph.D., President of the Company will be presenting at The Inaugural EF Hutton Global Conference, which will be held on May 10-11, 2023, at the Plaza Hotel in the heart of New York City. NanoViricides is presenting on May 10th.

Benzinga

uniQure To Rally Around 162%? Here Are 10 Other Analyst Forecasts For Tuesday

UBS cut the price target for Honeywell International Inc. (NASDAQ: HON) from $193 to $185. UBS analyst Chris Snyder maintained a Sell rating. Honeywell shares fell 0.2% to $191.99 in pre-market trading. Credit Suisse raised the price target for uniQure N.V. (NASDAQ: QURE) from $51 to $55. Credit Suisse analyst Judah Frommer maintained an Outperform rating on the stock. uniQure shares jumped 5.2% to close at $21.00 on Monday. Piper Sandler cut the price target for Dollar General Corporation (NYSE: DG) from $288 to $275. Piper Sandler analyst Peter Keith maintained an Overweight rating. Dollar General shares gained 1.4% to $219.11 in pre-market trading. EF Hutton slashed the price target for NanoViricides, Inc. (NYSE: Full story available on Benzinga.com

Benzinga

Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday

Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per share in cash. Onion Global Limited (NYSE: OG) jumped 90.6% to close at $0.7624 on Thursday. InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares surged 81% to close at $8.00 on Thursday after gaining over 12% on Wednesday. Minerva Neurosciences, Inc. (NASDAQ: NERV) gained 75.4% to close at $4.70. Missfresh Limited (NASDAQ: MF) shares climbed 51.7% to close at $0.1746 after dropping 7% on Wednesday. NanoViricides, Inc. (NYSE: NNVC) climbed 48.4% to close at $3.65 after the company announced it has begun drug development to combat Monkeypox virus. ZW Data Action Technologies Inc. (NASDAQ: CNET) jumped 44.4% to close at $0.83. ZW Data Action Technologies recently collaborated with Forbes Global Alliance to build the Forbes China Group Digital Collection Platform to launch NFT Products and jointly operate the platform data. Yellow Corporation (NASDAQ: YELL) rose 42.2% to close at $6.70 after the company swung to a profit for the second quarter. Global Blood Therapeutics, Inc. (NASDAQ: GBT) gained 41.4% to close at $47.99 following a report suggesting the company is attracting takeover interest. According to a Bloomberg report, citing people familiar with the matter, some large pharmaceutical companies are looking into a potential deal. Applied DNA Sciences, Inc. (NASDAQ: APDN) climbed 40% to settle at $5.74 as the company reported pricing of $12 million upsized offering. Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares jumped 38.1% to settle at $0.1560 after gaining around 9% on Wednesday. Greenpro Capital Corp. (NASDAQ: GRNQ) gained 37.7% to close at $2.41 after climbing around 14% on Tuesday after climbing 28% on Wednesday. Quhuo Limited (NASDAQ: QH) rose 37.6% to close at $0.45. Forge Global Holdings, Inc. (NYSE: FRGE) jumped 33% to close at $6.05. Forge Global is expected to report Q2 financial results on August 11, 2022. Legacy Housing Corporation (NASDAQ: LEGH) jumped 30.4% to close at $17.62 after the company late Wednesday re-stated Q1, Q2 and Q3 interim financial statements for FY21. GeoVax Labs, Inc. (NASDAQ: GOVX) jumped 30.3% to close at $3.57. Geovax Labs posted a Q2 loss of $0.21 per share. GreenLight Biosciences Holdings (NASDAQ: GRNA) shares rose 27.6% to close at $4.16 after jumping over 25% on Wednesday. Samsung Biologics and the company recently announced the completion of the first commercial-scale engineering run for the companies' mRNA production partnership. Waitr Holdings Inc. (NASDAQ: WTRH) jumped 26.9% to settle at $0.4288. Society Pass Incorporated (NASDAQ: SOPA) jumped 26.2% to close at $2.36 after reporting 2Q 2022 and 1H 2022 financial results. Exicure, Inc. (NASDAQ: XCUR) shares gained 25.6% to close at $2.50 after climbing around 27% on Wednesday. BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 23.2% to close at $13.74 after the company reported better-than-expected Q2 EPS and sales results. The company also announced the FDA has lifted its partial clinical hold on the BCX9930 program. Immunic, Inc. (NASDAQ: IMUX) gained 23.1% to close at $4.79 following Q2 results. PagSeguro Digital Ltd. (NYSE: PAGS) gained 22.9% to close at $15.03. TTM Technologies, Inc. (NASDAQ: TTMI) rose 22.4% to close at $16.53 following upbeat Q2 results. Altice USA, Inc. (NYSE: ATUS) surged 21.5% to close at $11.75 following strong quarterly sales. Amesite Inc. (NASDAQ: AMST) gained 20.9% to close at $0.52. Pintec Technology Holdings Limited (NASDAQ: PT) jumped 18.5% to close at $1.2201. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) jumped 18.8% to close at $0.2642. Precigen, Inc. (NASDAQ: PGEN) jumped 18.4% to settle at $2.12. Digital Brands Group, Inc. (NASDAQ: DBGI) rose 16.7% to close at $0.14. Digital Brands Group, last month, received a determination letter from the Nasdaq stating that the Company has not regained compliance. MercadoLibre, Inc. (NASDAQ: MELI) rose 16.2% to close at $1,034.83 following better-than-expected quarterly ...

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

No prior dividend records found.

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
Sep 24, 20191-for-20reverse split
Sep 10, 20131-for-3.5reverse split